Sanofi-Aventis ADS News, Sanofi-Aventis ADS Quote, SNY Quote

Sanofi-Aventis ADS (NY:SNY) Delayed: 54.50 +0.29 (0.53%)	Trade Now!
Previous Close	$54.21	52 Week High	$55.69
Open	$54.05	52 Week Low	$33.03
Day High	$54.68	P/E	N/A
Day Low	$54.03	EPS	$0.00
Volume	1,646,118

May 17, 2013 08:04 AM Sanofi (SNY) Reports JAKARTA Met Primary Endpoint in Both Groups
May 17, 2013 08:00 AM Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
May 17, 2013 08:00 AM Alnylam Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 (ALAS-1) for the Treatment of Porphyria
May 16, 2013 05:49 PM BioMarin Announces BMN-673 Data in Breast and Ovarian Cancers to be Released at ASCO
May 16, 2013 08:00 AM Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month
May 15, 2013 04:41 PM Buffett's Berkshire Hathaway Enters Chicago Bridge & Iron (CBI), Sells Archer-Daniels-Midland (ADM), General Dynamics (GD)
May 15, 2013 04:00 PM Alnylam to Webcast Presentation at 2013 UBS Global Healthcare Conference
May 15, 2013 06:14 AM Sanofi (SNY), Regeneron (REGN) Commence COMPARE, ASCERTAIN of Sarilumab
May 15, 2013 01:00 AM Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
May 14, 2013 09:11 AM BioMarin to Present at the UBS Global Healthcare Conference

Feb 11, 2013 10:02 AM Sanofi Antitrust Filing On Regeneron (REGN) Lights Up Rumor Mill
Feb 7, 2013 08:31 AM Sanofi-Aventis (SNY) Q4 EPS Falls to EUR1.19
Jul 26, 2012 09:02 AM Sanofi (SNY) Reports Weaker Q2 Results; Plavix Sales Continue Falling
Apr 27, 2012 06:54 AM Sanofi (SNY) Posts Improved Q1 EPS, Revenue Results

May 17, 2013 08:04 AM Sanofi (SNY) Reports JAKARTA Met Primary Endpoint in Both Groups
May 15, 2013 04:41 PM Buffett's Berkshire Hathaway Enters Chicago Bridge & Iron (CBI), Sells Archer-Daniels-Midland (ADM), General Dynamics (GD)
May 15, 2013 06:14 AM Sanofi (SNY), Regeneron (REGN) Commence COMPARE, ASCERTAIN of Sarilumab
Apr 23, 2013 08:10 AM Sanofi, KaloBios Pharmaceuticals (KBIO) Granted FDA Fast Track Status for KB001A
Apr 3, 2013 02:32 PM Notable 52-Week Highs and Lows of the Day 04/03: (FNP) (ASTX) (SNY) High; (X) (AKS) (STSI) Low
Apr 3, 2013 09:59 AM Dupilumab Could End of Being 'Blockbuster' Asthma Drug - Analyst (SNY) (REGN)
Mar 26, 2013 07:50 AM Jacobs (JEC) Contracted for Engineering Services by Sanofi Pasteur; No Value Disclosed
Mar 25, 2013 06:11 AM Sanofi (SNY), Transgene Enter Long-Term Immunotherapy Development
Mar 22, 2013 08:56 AM Sanofi's (SNY) Genzyme Receives Positive CHMP AUBAGIO as MS Treatment
Mar 21, 2013 03:09 PM Sanofi (SNY) Unit Issues Encouraging Update for First-Year of LEMTRADA Phase III in MS

May 17, 2013 08:00 AM Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
May 17, 2013 08:00 AM Alnylam Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 (ALAS-1) for the Treatment of Porphyria
May 16, 2013 05:49 PM BioMarin Announces BMN-673 Data in Breast and Ovarian Cancers to be Released at ASCO
May 16, 2013 08:00 AM Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month
May 15, 2013 04:00 PM Alnylam to Webcast Presentation at 2013 UBS Global Healthcare Conference
May 15, 2013 01:00 AM Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
May 14, 2013 09:11 AM BioMarin to Present at the UBS Global Healthcare Conference
May 14, 2013 07:00 AM Jack Green Joins Verastem as Chief Financial Officer
May 13, 2013 10:00 AM PatientsLikeMe and CISCRP Team up with Sanofi to Spotlight Medical Heroes and Clinical Trial Participation
May 13, 2013 07:00 AM Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference

Entities mentioned with SNY